ArticlePulmonary circulation2016

Assessment of the effects of hepatic impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Reiner Frey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.